NOTRELOAD AI
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD (BETA)
  • XY Feed
  • 24-HOUR Pass →
Sign in Subscribe

Assertio Shares Jump as Garda Raises All-Cash Buyout Offer to $21.80 Per Share ($153M Deal)

Garda raised bid to $21.80/share cash to buy Assertio, boosting stock ~17%. Deal gives shareholders higher, certain payout.

Assertio Shares Jump as Garda Raises All-Cash Buyout Offer to $21.80 Per Share ($153M Deal)
Credit: Assertio
Already have an account? Sign in.
05/04/2026 · 9:34 AM
ASRT
/ Don’t stop at just one post.

Related↓

Assertio Agrees to $125 Million All-Cash Buyout by Garda Therapeutics
04/08/2026 · 4:31 PM

Assertio Agrees to $125 Million All-Cash Buyout by Garda Therapeutics

Assertio is being bought by Garda for $18/share + possible bonus if Sprix hits goals; deal closes June 2026, company goes private.

/ Subscriber only
/ Read more

Feed↓

Mirum’s Volixibat Delivers Major Win in VISTAS Study – First Potential Treatment for Severe Itching in PSC
05/04/2026 · 10:13 AM

Mirum’s Volixibat Delivers Major Win in VISTAS Study – First Potential Treatment for Severe Itching in PSC

Mirum’s drug volixibat reduced severe itching in PSC patients in a Phase 2 trial; next step is FDA filing in 2026.

/ Subscriber only
Limited Upside for AMD? HSBC Downgrades Stock to Hold
Featured/ 05/04/2026 · 10:01 AM

Limited Upside for AMD? HSBC Downgrades Stock to Hold

HSBC downgraded AMD after a big rally. Stock looks expensive now, limited short-term upside, but long-term outlook still strong.

/ Subscriber only
Eli Lilly Stock Falls on Foundayo Liver Report
Featured/ 05/04/2026 · 9:02 AM

Eli Lilly Stock Falls on Foundayo Liver Report

Lilly stock dropped after a single liver issue report tied to its new weight-loss pill Foundayo, but the evidence is weak and likely an overreaction.

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2026
Email address Subscribe